MECOCCI, Patrizia
 Distribuzione geografica
Continente #
NA - Nord America 10.641
EU - Europa 9.593
AS - Asia 3.309
SA - Sud America 30
Continente sconosciuto - Info sul continente non disponibili 17
AF - Africa 8
OC - Oceania 6
Totale 23.604
Nazione #
US - Stati Uniti d'America 10.593
IT - Italia 2.872
IE - Irlanda 1.803
UA - Ucraina 1.526
SE - Svezia 1.216
SG - Singapore 1.108
HK - Hong Kong 764
VN - Vietnam 725
FI - Finlandia 458
RU - Federazione Russa 386
CN - Cina 378
DE - Germania 361
FR - Francia 327
GB - Regno Unito 186
KR - Corea 113
CH - Svizzera 107
AT - Austria 100
TR - Turchia 85
PL - Polonia 49
NL - Olanda 48
BE - Belgio 37
CA - Canada 35
CZ - Repubblica Ceca 30
UZ - Uzbekistan 30
GR - Grecia 23
IR - Iran 23
MY - Malesia 20
RO - Romania 20
EU - Europa 17
BR - Brasile 16
IN - India 16
LB - Libano 16
MX - Messico 11
BG - Bulgaria 8
PH - Filippine 8
ES - Italia 7
JP - Giappone 5
AE - Emirati Arabi Uniti 4
CO - Colombia 4
LT - Lituania 4
LV - Lettonia 4
SK - Slovacchia (Repubblica Slovacca) 4
AU - Australia 3
CL - Cile 3
DK - Danimarca 3
EC - Ecuador 3
LK - Sri Lanka 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
SA - Arabia Saudita 3
AL - Albania 2
IL - Israele 2
IQ - Iraq 2
IS - Islanda 2
MA - Marocco 2
PE - Perù 2
UG - Uganda 2
AR - Argentina 1
BO - Bolivia 1
CI - Costa d'Avorio 1
DZ - Algeria 1
EG - Egitto 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
JM - Giamaica 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
MT - Malta 1
NO - Norvegia 1
OM - Oman 1
SV - El Salvador 1
TN - Tunisia 1
VA - Santa Sede (Città del Vaticano) 1
Totale 23.604
Città #
Chandler 1.972
Dublin 1.801
San Mateo 897
Jacksonville 836
Singapore 808
Boardman 780
Hong Kong 760
Dong Ket 722
Santa Clara 580
Altamura 525
Medford 467
Princeton 463
Lawrence 397
Wilmington 344
Perugia 314
Andover 268
Ann Arbor 230
Beijing 170
Des Moines 132
Rome 127
Saint Petersburg 121
Milan 107
Helsinki 104
Norwalk 101
Seoul 100
Redmond 94
Falls Church 83
Los Angeles 80
Izmir 74
Ashburn 73
San Paolo di Civitate 70
Vienna 64
Woodbridge 60
Houston 53
Redwood City 46
New York 44
Dallas 38
Munich 38
Dearborn 34
Palermo 34
Brussels 33
Lappeenranta 32
Florence 29
Terni 29
Bologna 28
Moscow 27
Padova 27
Naples 26
Auburn Hills 25
Kraków 25
Prato 25
Shanghai 25
Bari 24
Ardabil 22
Monmouth Junction 21
Toronto 21
Den Haag 19
Brno 17
Chicago 17
Frankfurt Am Main 16
Caserta 14
Civitavecchia 14
Brescia 13
Torino 13
Turin 13
Verona 13
Catania 12
Genoa 12
Napoli 11
Assisi 9
Cornigliano 9
Lausanne 9
Lugano 9
Paris 9
Venezia 9
Bergamo 8
Fairfield 8
San Diego 8
Pescara 7
Seattle 7
Sesto Fiorentino 7
Tappahannock 7
Udine 7
Collazzone 6
Frankfurt am Main 6
London 6
Pisa 6
Tyresö 6
Vernio 6
Castelnuovo Rangone 5
Cesena 5
Chiaravalle 5
Concesio 5
Istanbul 5
Kuala Lumpur 5
Livorno 5
Nanning 5
Olomouc 5
Parma 5
Philadelphia 5
Totale 14.818
Nome #
Validazione della versione italiana della Geriatric Depression Scale a 5 item in tre differenti setting assistenziali 1.415
I disturbi comportamentali “clinicamente rilevanti” nella demenza vascolare, nella demenza a corpi di Lewy e nella demenza di Alzheimer: studio su 921 pazienti anziani. 289
Musicalmente: sviluppo di un paradigma per la valutazione dell’efficacia della musicoterapia nel trattamento della demenza 159
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 118
Antiossidanti plasmatici e longevità: studio su centenari sani 112
The brain of the elderly between normality and pathology: Techniques and technologies for the evaluation 109
Validation study of the Italian Addenbrooke’s Cognitive Examination Revised in a young-old and old-old population 108
Fracture prevention service to bridge the osteoporosis care gap 107
Antioxidants for the treatment of mild cognitive impairment. (Review) 104
Platelet MAO-B activity and vitamin B12 in old age dementias. 103
Guidelines for the treatment of Alzheimer’s disease from the Italian Association of Psychogeriatrics. 103
Oxidative stress and dementia: new perspectives in AD pathogenesis. 99
Effect of acetyl-L-carnitine on serum levels of cortisol and adrenocorticotropic hormone and its clinical effect in patients with senile dementia of Alzheimer type 99
Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease. 95
Alterazioni biochimiche nel cervello di soggetti con ipertensione cronica e in pazienti con demenza di Alzheimer in fase precoce valutate mediante risonanza magnetica spettroscopica 94
The orthogeriatric management: an inseparable duo to foster appropriate care 94
Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. 93
Lysosomal enzymes in alzheimer disease and type 2 diabetes mellitus patients 89
Dementia, depression and parkinsonism: A frequent association in the elderly. 88
Axonal injury within language network in primary progressive aphasia 88
Heart disease and vascular risk factors in the cognitively impaired elderly: implications for Alzheimer's dementia 87
Hippocampal atrophy in people with memory deficits: results from the population-based IPREA study 85
Automated Hippocampal Subfield Measures as Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease in Two Independent Cohorts 85
La risonanza magnetica spettroscopica differenzia il Mild Cognitive Impairment dal normale invecchiamento cerebrale 84
Attività dell'Aconitasi Mitocondriale nella demenza di Alzheimer e nel Mild cognitive impairment 84
Association of increased carotid intima-media thickness and lower plasma levels of vitamin C and vitamin E in old age subjects: implications for Alzheimer's disease 83
The effects of aging and endurance exercise on cardiovascular performance in healthy elderly: a review of the literature. 83
Interaction of CTSD and A2M polymorphisms in the risk for Alzheimer's disease. 83
Predicting progression of Alzheimer's disease using ordinal regression 82
Alleles that increase risk for type 2 diabetes mellitus are not associated with increased risk for Alzheimer’s disease 82
Approccio diagnostico ai disturbi cognitivi in corso di patologie somatiche nell’anziano. 82
Lysosomal beta-Galactosidase and beta-Hexosaminidase Activities Correlate with Clinical Stages of Dementia Associated with Alzheimer's Disease and Type 2 Diabetes Mellitus 82
Vitamin D supplementation with calcidiol and cholecalciferol among oldest-old persons 82
Pharmaceutical treatment of cognitive disorders in Alzheimer's disease. 81
Rapidly progressive aphasic dementia with motor neuron disease: A distinctive clinical entity 81
Influence of +1245 A/G MT1A polymorphism on advanced glycation end-products (AGEs) in elderly: effect of zinc supplementation 80
Insight, cognition and quality of life in Alzheimer's disease. 80
Comparative kinetics of oxiracetam in serum and CSF of patients with dementia of Alzheimer type 79
Cognitive Impairment Is the Major Risk Factor for Development of Geriatric Syndromes during Hospitalization: Results from the GIFA Study 79
An ontology-based personalization of health-care knowledge to support clinical decisions for chronically ill patients 79
Proton magnetic resonance spectroscopy reveals similar white matter biochemical changes in patients with chronic hypertension and early Alzheimer's disease. 79
Paziente anziano, paziente geriatrico e medicina della complessità. Fondamenti di Gerontologia e Geriatria (III edizione) 78
Common genetic variants influence human subcortical brain structures. 77
Neuropsychological results of long-term therapy with oxiracetam in DAT/MID patients in comparison with a control group 77
Antioxidants micronutrients in the prevention of age-related diseases: focus on Alzheimer’s disease 77
Normative data for the ACE-R in an Italian population sample. 77
Antioxidant enzyme activities in healthy old subjects: influence of age, gender and zinc status : Results from the Zincage Project. 77
Genetic predisposition to increased blood cholesterol and triglyceride lipid levels and risk of Alzheimer disease: a mendelian randomization analysis. 76
Generalizability of the Disease State Index Prediction Model for Identifying Patients Progressing from Mild Cognitive Impairment to Alzheimer's Disease. 76
Effects of zinc supplementation on antioxidant enzyme activities in healthy old subjects. 76
Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. 75
Blood pressure and functional aspects of the aging brain. 75
Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementia. 75
Neuroendocrine markers in aging brain: clinical and neurobiological significance of dexamethasone suppression test 74
Metabolic syndrome and risk of dementia in older adults. 74
Alzheimer's disease: clinical trials and drug development. 74
Nutraceuticals in cognitive impairment and Alzheimer's disease 74
The orthogeriatric comanagement improves clinical outcomes of hip fracture in older adults 74
Circulating Proteomic Signatures of Chronological Age 73
Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy. 73
Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementia. 73
Deterioramento cognitivo e sviluppo di sindromi geriatriche durante il ricovero ospedaliero: risultati dello studio GIFA 73
Gli effetti dell’anemia e dell’emotrasfusione sugli indicatori clinici nel paziente anziano con frattura di femore. 73
Application of a MRI based index to longitudinal atrophy change in Alzheimer disease, mild cognitive impairment and healthy older individuals in the AddNeuroMed cohort 72
FASTKD2 is associated with memory and hippocampal structure in older adults 72
Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. 72
Altered mitochondrial membrane fluidity in AD brain. 72
Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology. 72
The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey 71
Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment 71
The AddNeuroMed framework for multi-centre MRI assessment of Alzheimer's disease: experience from the first 24 months 71
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 71
Cognitive Decline and Alzheimer's Disease in Old Age: A Sex-Specific Cytokinome Signature 71
Area-specific differences in OH8dG and mtDNA4977 levels in Alzheimer disease patients and aged controls. 70
AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America 70
Paziente anziano, Paziente geriatrico 69
Age and sex influence on oxidative damage and functional status in human skeletal muscle. 69
Topics in clinical pharmacology: cardiovascular and diabetes mellitus. 68
Le demenze vascolari 68
Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer's disease 68
Antioxidant agents in Alzheimer’s disease 68
Anticholinergic burden and functional status in older people with cognitive impairment: Results from the ReGAl project 68
High vitamin E plasma levels and low low-density lipoprotein oxidation are associated with the absence of atherosclerosis in octogenarians. 67
Elevati livelli plasmatici delle forme di vitamina E e riduzione del rischio di malattia di Alzheimer in età avanzata 67
Validation of the five-item geriatric depression scale in elderly subjects in three different settings. 67
Antioxidant profile and early outcome in stroke patients. 67
Age-dependent increases in oxidative damage to DNA, lipids, and proteins in human skeletal muscle 66
AddNeuroMed--the European collaboration for the discovery of novel biomarkers for Alzheimer's disease. 66
Different antioxidant profiles in Italian centenarians: the Sardinian peculiarity. 65
Increased protein and lipid oxidative damage in mitochondria isolated from lymphocytes from patients with Alzheimer's disease: insights into the role of oxidative stress in Alzheimer's disease and initial investigations into a potential biomarker for this dementing disorder 65
H-1-MR spectroscopy differentiates mild cognitive impairment from normal brain aging 65
Antibiotic use and associated factors in a large sample of hospitalised older people 64
Lower serum levels of IL-13 is associated with increased carotid intima-media thickness in old age subjects 64
Afasia progressiva associata a malattia del motoneurone. 63
Il ruolo dei fattori di rischio vascolare nei sottotipi di mild cognitive impairment. Risultati del progetto ReGAl 63
Influenza della comorbilità e dello stato cognitivo sulle attività strumentali della vita quotidiana nei soggetti con Mild Cognitive Impairment Amnesico (aMCI): risultati del Progetto ReGAl. 63
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing 63
The Caregiver Burden Inventory in evaluating the burden of caregivers of elderly demented patients: results from a multicenter study 62
Alzheimer's disease susceptibility variants in the MS4A6A gene are associated with altered levels of MS4A6A expression in blood. 62
Associazione tra indice di Winsor e prestazioni cognitive in soggetti anziani viventi in comunità. 62
Totale 9.433
Categoria #
all - tutte 112.942
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 112.942


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.317 0 0 0 0 0 74 265 75 491 159 60 193
2020/20214.153 41 219 181 236 1.067 236 250 31 451 334 316 791
2021/20223.856 158 686 128 245 137 70 71 1.130 120 121 447 543
2022/20236.935 501 1.377 76 528 536 698 89 342 2.434 60 205 89
2023/20242.985 204 331 157 97 29 26 480 130 426 124 504 477
2024/20252.532 186 745 331 180 781 309 0 0 0 0 0 0
Totale 24.948